Phase II Clinical Trial to Evaluate the Benefits of Postconditioning in ST-Elevation Myocardial Infarction (STEMI)

A phase 1/2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 103 participants.

Also called NCT01324453

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 1/2
Enrolled
  • 103 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01324453
Other papers using this trial's data
  • NHLBI-Sponsored Randomized Trial of Postconditioning During Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction Circulation research, 2019-03 DOI, PubMed 30602360, PMC6417923 In the PMC Open Access subset under a licence that is not Creative Commons.

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01324453. Randomized; no masking; primary purpose treatment. Start 2011-03 (registry gives no type); primary completion 2016-11 (actual). Results posted on 2018-04-17.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Phase II Clinical Trial to Evaluate the Benefits of Postconditioning in ST-Elevation Myocardial Infarction (STEMI)
Condition
Acute Myocardial Infarction
Intervention (Procedure)
Post Conditioning + Primary PCI
Intervention (Procedure)
Standard Primary PCI
Lead sponsor
Minneapolis Heart Institute Foundation (class: other)
Collaborator
National Heart, Lung, and Blood Institute (NHLBI) (class: US National Institutes of Health)

Record details

Record id
cardio:ct-nct01324453
Content hash
181209d853c34d913424928b68b0ea45648024fc2c5a15952bf18881714b5b8a